Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Elke M.G.J. De Jong"'
Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review
Autor:
Wynanda A. van Enst, Ying Chao Weng, Sophie A. C. Wanten, Marieke M.B. Seyger, Ewout M. Baerveldt, Bernd W.M. Arents, Elke M.G.J. de Jong, Juul M.P.A. van den Reek
Publikováno v:
Acta Dermato-Venereologica, Vol 104 (2024)
Telemedicine, the provision of remote healthcare, has gained prominence, accelerated by the COVID-19 pandemic. It has the potential to replace routine in-person follow-up visits for patients with chronic inflammatory skin conditions. However, it rema
Externí odkaz:
https://doaj.org/article/5847ed69eac948f18b4afd6332ef6913
Autor:
Tamara W. van Hal, Michelle L.M. Mulder, Mark H. Wenink, Frank H.J. van den Hoogen, Jake S.F. Maurits, Marcel C. Pasch, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to joint damage. While screening questionnaires have been developed, their performance varies. The objective of this study was to develop a referral tool for dermat
Externí odkaz:
https://doaj.org/article/95e12fde9eeb4e12bb62a55c55dfc84e
Autor:
Elke L.M. ter Haar, Eline E. ten Bruin, Ewald E. Bronkhorst, Rinke J. Borgonjen, Marloes M. Kleinpenning, Else N. Kop, M. Birgitte Visch, Peter C.M. van de Kerkhof, Elke M.G.J. de Jong, Satish F.K. Lubeek
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Optimal selection of systemic therapy in older adults with psoriasis can be challenging, due to sparse evidence-based guidance. This multicentre retrospective study investigated the safety of systemic therapy with causality assessment in a real-world
Externí odkaz:
https://doaj.org/article/b6dd0bf362624e779b7876286616c000
Autor:
Marloes E. van Muijen, Sarah E. Thomas, Douwe Vellinga, Silke Bouwman, Martijn B.A. van Doorn, Klaziena Politiek, Marisol E. Otero, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/f56aae0ea10b4cf7b759c218087ff36e
Autor:
Tamara W. van Hal, Michelle L.M. Mulder, Mark H. Wenink, Marcel C. Pasch, Frank H.J. van den Hoogen, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Patients with psoriasis are at risk of developing psoriatic arthritis, which can lead to irreversible joint damage. However, a proportion of patients with psoriasis and concomitant psoriatic arthritis remain undiscovered in practice. The aims of this
Externí odkaz:
https://doaj.org/article/bff523826c6c47b995ee40446825e09b
Autor:
Finola M. Bruins, Maartje R. van Acht, Inge M.G.J. Bronckers, Hans M.M. Groenewoud, Elke M.G.J. de Jong, Marieke M.B. Seyger
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
In paediatric psoriasis, few studies have evaluated methotrexate effectiveness, adverse events and folic acid regimen. Therefore this study prospectively assessed methotrexate adverse events and effectiveness in paediatric patients with psoriasis in
Externí odkaz:
https://doaj.org/article/04f8780935eb4811adaab3f224438a00
Autor:
Marloes E. van Muijen, Sarah E. Thomas, Hans M.M. Groenewoud, Marisol E. Otero, Paul M. Ossenkoppele, Marcellus D. Njoo, Sharon R.P. Dodemont, Else N. Kop, Maartje A.M. Berends, Marjolein I.A. Koetsier, Johannes M. Mommers, John E.M. Körver, Ron A. Tupker, Marjolein S. de Bruin-Weller, Lizelotte J.M.T. Weppner-Parren, Bas Peters, Marloes M. Kleinpenning, Astrid L.A. Kuijpers, W. Peter Arnold, Paula P.M. van Lümig, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Real-world evidence, directly comparing the effectiveness of interleukin (IL)17-inhibitors, IL23-inhibitors, tumour necrosis factor alpha (TNF-α)-inhibitors and an IL12/23-inhibitor in psoriasis, is scarce. The aim of this study was to directly comp
Externí odkaz:
https://doaj.org/article/e146b3b81ecf4e69ba49684069d330cc
Autor:
Linda Davidson, Juul M.P.A. van den Reek, Mariolina Bruno, Florence van Hunsel, Ron M.C. Herings, Vasiliki Matzaraki, Collins K. Boahen, Vinod Kumar, Hans M.M. Groenewoud, Frank L. van de Veerdonk, Mihai G. Netea, Elke M.G.J. de Jong, Bart Jan Kullberg
Publikováno v:
The Lancet Regional Health. Europe, Vol 13, Iss , Pp 100266- (2022)
Summary: Background: Biologics directed against the T-helper (Th)-17 pathway have been approved for several inflammatory diseases. Interleukin (IL)-17 is involved in anti-Candida host defense, and clinical trials suggested increased candidiasis incid
Externí odkaz:
https://doaj.org/article/10c27b516f674a5996918493da5804b9
Autor:
Linda Davidson, Juul M.P.A. van den Reek, Florence van Hunsel, Elke M.G.J. de Jong, Bart Jan Kullberg
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Genetic defects in interleukin-12/23/17 immunity are associated with an increased risk of Staphylococcus aureus and herpesvirus skin infections. This study analysed spontaneous safety reports from the WHO Pharmacovigilance Center of bacterial skin or
Externí odkaz:
https://doaj.org/article/ad8bdbe8f4744ddc92d3f71b0985919f
Autor:
Selma Atalay, Lara S. van der Schoot, Laura Vandermaesen, Lieke J. van Vugt, Mascha Eilander, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 101, Iss 5, p adv00463 (2021)
Dose reduction of biologics for psoriasis could contribute to lower drug exposure. This study evaluated a one-step, tightly controlled, biologic dose reduction strategy in a prospective daily practice cohort. In patients with psoriasis with low disea
Externí odkaz:
https://doaj.org/article/12986750a9e2469bb6dfe833a2c56f72